Myc-mediated Apoptosis is Blocked by Ectopic Expression of Bcl-2

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1993 Apr 1

PMID 8455620

Citations 62

Authors

A J Wagner

M B Small

N Hay

Affiliations

Soon will be listed here.

Abstract

The product of the c-myc proto-oncogene is an important positive regulator of cell growth and proliferation. Recently, c-Myc has also been demonstrated to be a potent inducer of apoptosis when expressed in the absence of serum or growth factors. To further examine Myc-induced apoptosis, we coexpressed the proto-oncogene bcl2, which has been shown to block apoptosis in other systems, with c-myc in serum-deprived Rat 1a fibroblasts. Here we report that ectopic expression of bcl2 specifically blocks apoptosis induced by constitutive c-myc expression. Constitutive c-myc expression in serum-deprived Rat 1a cells caused a > 15-fold increase in the number of dead cells, accompanied by DNA fragmentation. However, coexpression of bcl2 with c-myc in these cells led to a 10-fold increase in the number of live cells and a significant decrease in DNA fragmentation. Thus, Bcl-2 effectively inhibits Myc-induced apoptosis in serum-deprived Rat 1a fibroblasts without blocking entry into the cell cycle. These results imply that apoptosis serves as a protective mechanism to prevent tumorigenicity elicited by deregulated Myc expression. This protective mechanism is abrogated, however, by Bcl-2 and therefore may explain the synergism between Myc and Bcl-2 observed in certain tumor cells.

Citing Articles

miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.

Huang W, Paul D, Calin G, Bayraktar R Cells. 2024; 13(1).

PMID: 38201290 PMC: 10778542. DOI: 10.3390/cells13010084.

Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer.

Fairlie W, Lee E Int J Mol Sci. 2021; 22(6).

PMID: 33799592 PMC: 8000576. DOI: 10.3390/ijms22062841.

Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.

Liu Z, Yoshimi A, Wang J, Cho H, Chun-Wei Lee S, Ki M Cancer Discov. 2020; 10(6):806-821.

PMID: 32188705 PMC: 8188517. DOI: 10.1158/2159-8290.CD-19-1330.

GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways.

Farria A, Mustachio L, Coban Akdemir Z, Dent S Oncotarget. 2019; 10(56):5847-5858.

PMID: 31645904 PMC: 6791378. DOI: 10.18632/oncotarget.27226.

Overall Downregulation of mRNAs and Enrichment of H3K4me3 Change Near Genome-Wide Association Study Signals in Systemic Lupus Erythematosus: Cell-Specific Effects.

Zhang Z, Shi L, Song L, Maurer K, Petri M, Sullivan K Front Immunol. 2018; 9:497.

PMID: 29593737 PMC: 5859352. DOI: 10.3389/fimmu.2018.00497.

References

Nau M, Brooks B, Battey J, Sausville E, Gazdar A, Kirsch I . L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature. 1985; 318(6041):69-73. DOI: 10.1038/318069a0. View

Borzillo G, Endo K, Tsujimoto Y . Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene. 1992; 7(5):869-76. View

Rustgi A, Dyson N, Bernards R . Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature. 1991; 352(6335):541-4. DOI: 10.1038/352541a0. View

Wyllie A, KERR J, Currie A . Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68:251-306. DOI: 10.1016/s0074-7696(08)62312-8. View

Kirschmeier P, Housey G, Johnson M, Perkins A, Weinstein I . Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA. 1988; 7(3):219-25. DOI: 10.1089/dna.1988.7.219. View

Wolf D, Rotter V . Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci U S A. 1985; 82(3):790-4. PMC: 397132. DOI: 10.1073/pnas.82.3.790. View

Makover D, Cuddy M, Yum S, Bradley K, Alpers J, Sukhatme V . Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT. Oncogene. 1991; 6(3):455-60. View

Pechatnikov V, Afanasyev V, Korol B, Korneev V, Rochev YuA , Umansky S . Flow cytometry analysis of DNA degradation in thymocytes of gamma-irradiated or hydrocortisone treated rats. Gen Physiol Biophys. 1986; 5(3):273-84. View

Reed J, Tanaka S, Cuddy M . Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines. Cancer Res. 1992; 52(10):2802-5. View

10.

Eilers M, Schirm S, Bishop J . The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 1991; 10(1):133-41. PMC: 452621. DOI: 10.1002/j.1460-2075.1991.tb07929.x. View

11.

Marcu K, Bossone S, Patel A . myc function and regulation. Annu Rev Biochem. 1992; 61:809-60. DOI: 10.1146/annurev.bi.61.070192.004113. View

12.

Takahashi T, DAmico D, Chiba I, Buchhagen D, Minna J . Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J Clin Invest. 1990; 86(1):363-9. PMC: 296731. DOI: 10.1172/JCI114710. View

13.

Wagner A, Le Beau M, Diaz M, Hay N . Expression, regulation, and chromosomal localization of the Max gene. Proc Natl Acad Sci U S A. 1992; 89(7):3111-5. PMC: 48814. DOI: 10.1073/pnas.89.7.3111. View

14.

Evan G, Wyllie A, GILBERT C, Littlewood T, Land H, Brooks M . Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992; 69(1):119-28. DOI: 10.1016/0092-8674(92)90123-t. View

15.

Nunez G, Seto M, Seremetis S, Ferrero D, Grignani F, Korsmeyer S . Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. Proc Natl Acad Sci U S A. 1989; 86(12):4589-93. PMC: 287316. DOI: 10.1073/pnas.86.12.4589. View

16.

McDonnell T, Korsmeyer S . Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 1991; 349(6306):254-6. DOI: 10.1038/349254a0. View

17.

Finke J, Fritzen R, Ternes P, Trivedi P, Bross K, Lange W . Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood. 1992; 80(2):459-69. View

18.

Shi Y, Glynn J, Guilbert L, Cotter T, Bissonnette R, Green D . Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 1992; 257(5067):212-4. DOI: 10.1126/science.1378649. View

19.

Reed J, Talwar H, Cuddy M, Baffy G, Williamson J, Rapp U . Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts. Exp Cell Res. 1991; 195(2):277-83. DOI: 10.1016/0014-4827(91)90374-4. View

20.

Chen-Levy Z, Nourse J, Cleary M . The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol. 1989; 9(2):701-10. PMC: 362647. DOI: 10.1128/mcb.9.2.701-710.1989. View